Bausch Health Cos - 15 Year Stock Price History | BHC
Historical daily share price chart and data for Bausch Health Cos since 2011 adjusted for splits and dividends. The latest closing stock price for Bausch Health Cos as of September 17, 2026 is 5.65.
- The all-time high Bausch Health Cos stock closing price was 262.52 on August 05, 2015.
- The Bausch Health Cos 52-week high stock price is 8.00, which is 41.6% above the current share price.
- The Bausch Health Cos 52-week low stock price is 4.33, which is 23.4% below the current share price.
- The average Bausch Health Cos stock price for the last 52 weeks is 5.96.
| Bausch Health Cos Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 5.7042 | 7.2100 | 7.9000 | 4.4300 | 5.6500 | -18.71% |
| 2025 | 6.4322 | 7.9400 | 8.3400 | 4.3200 | 6.9500 | -13.77% |
| 2024 | 7.7760 | 7.7800 | 10.6100 | 5.2200 | 8.0600 | 0.50% |
| 2023 | 7.8278 | 6.2800 | 9.8500 | 5.7200 | 8.0200 | 27.71% |
| 2022 | 13.0150 | 27.7900 | 27.7900 | 4.5800 | 6.2800 | -77.25% |
| 2021 | 28.6747 | 21.3700 | 34.3800 | 21.3700 | 27.6100 | 32.74% |
| 2020 | 19.3725 | 29.9100 | 30.2500 | 12.9800 | 20.8000 | -30.48% |
| 2019 | 24.1289 | 20.2300 | 31.8900 | 18.8900 | 29.9200 | 61.99% |
| 2018 | 21.5133 | 21.7900 | 28.3200 | 14.8800 | 18.4700 | -11.12% |
| 2017 | 14.1830 | 15.2400 | 22.0500 | 8.5100 | 20.7800 | 43.11% |
| 2016 | 36.2500 | 98.5000 | 102.4000 | 13.6000 | 14.5200 | -85.72% |
| 2015 | 186.1722 | 144.4500 | 262.5200 | 70.3200 | 101.6500 | -28.97% |
| 2014 | 129.4231 | 116.9800 | 148.0000 | 106.7300 | 143.1100 | 21.90% |
| 2013 | 88.5800 | 60.7500 | 117.4200 | 60.7100 | 117.4000 | 96.42% |
| 2012 | 52.2736 | 47.9700 | 61.0300 | 43.7300 | 59.7700 | 28.01% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.129B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |